We Can End Diabetes Here At Home
The Manitoba Moonshot is a front-row seat watching one Canadian family trying to save the world from the devastation of type 2 diabetes.
But solving a worldwide pandemic isn’t enough. Unlike Pharma, the goal of the Lautt family is to prevent people from getting sick in the first place. They believe they can detect type 2 decades before any current testing.
If they can detect type 2 diabetes decades earlier, they can prevent people from getting sick in the first place.
They’ll use their scientific methods and financial gains to illustrate that investing in upstream healthcare interventions can be cost-effective for governments and save families from decades of needless suffering.
We spend 90% of our federal budget managing the health costs for the last ten years of a life. What if we shifted even SOME of that budget to the first 70 years into prevention?
We don't have billions of dollars. We can't solve diabetes in every single country all at once.
But what we can do with our handful of millions is we can solve diabetes in Manitoba. And if you can solve diabetes in Manitoba, then you've got something because this is one of the worst hit provinces in our country for incidence of diabetes. So we said, let's move the needle here.
John West
SciMar - Chief Development Officer
We don't have billions of dollars. We can't solve diabetes in every single country all at once.
But what we can do with our handful of millions is we can solve diabetes in Manitoba. And if you can solve diabetes in Manitoba, then you've got something because this is one of the worst hit provinces in our country for incidence of diabetes. So we said, let's move the needle here.
John West
SciMar - Chief Development Officer
SciMar is setting out to prove they are on the brink of a life-changing scientific breakthrough that has the power to save millions of lives.
Join us to witness a small Canadian company pushing boundaries, disrupting the status quo, and challenging the way things have been done for decades.
The time is now. This is a journey you don’t want to miss.
the lautt familY
At the center of SciMar’s work is the cutting-edge research of Dr. W. Wayne Lautt. In 1996, he made a discovery of a hormone called hepatalin that has the power to completely revolutionize the way the world prevents, detects, and treats type 2 diabetes.
Today, Dr. Lautt has teamed up with his son, Mick Lautt, his son-in-law, John West and a dedicated team of researchers to unveil their own moonshot. It has taken a family-sized effort to fuel SciMar’s vision and their mission is just about ready for lift off.
"There’s a hormone that’s involved, that none of us has thought about. Like, none of us. We were thinking. The whole world was thinking that when you administer insulin, the effect that you’re seeing is the direct effect of insulin acting on these various tissues. What we ended up showing was that….nope. Hepatalin is the missing link and people are going to have to recognize that. And if they don't, then they're just not going to be on the right train."
- dr. w. wayne lautt
Chief Scientific Officer, Co-Founder, SciMar Ltd.
"On every new frontier, there's one person or a small group of people who are the first. They're the ones that, you know, open up a new door and look in and go, oh, this is different than what we thought. That's what my dad's been doing."
- MICK LAUTT
Chief EXECUTIVE OFFICER, SciMar Ltd.
LEARNING FROM THE MISTAKES OF INSULIN
100 years after the discovery of insulin by Dr. Frederick Banting and Charles Best, another group of Canadians have made the next leap forward in the treatment of type 2 diabetes. But the Lautt family does not want history to repeat itself when they bring hepatalin to market.
With insulin, Banting thought he was being altruistic by giving away the patent. 100 years later, we see the Banting's best intentions eroded by the exponential rise of the cost of insulin - especially in the United States - making a life saving medicine unattainable to many who need it most.
When the Lautt family founded SciMar, they decided that the financial gains of this breakthrough would be reinvested in revolutionizing healthcare, advancing science, and protecting the most marginalized.
While we follow the final sprint to bring hepatalin to market, the Manitoba Moonshot will feature exclusive and personal interviews with Canadians from all walks of life who are currently face-to-face battling type 2 diabetes and numerous other health care issues.
‘Manitoba Moonshot’ will ask the tough questions about access to health care for marginalized communities across Canada, we are united with our northern neighbours and will focus on issues specific to the Indigenous community.
This isn’t just a channel following the Lautt family story. One of their main priorities is to showcase the excellent work being done in communities already.
Lifestyle interventions that we know anecdotally help people. Well, SciMar is investing in clinical trials with these partners to be able to provide quantifiable data that illustrates that investing in an ounce of prevention is far more valuable and cost effective than waiting for someone to get sick.‘Manitoba Moonshot’ will ask the tough questions about access to health care for marginalized communities across Canada, we are united with our northern neighbours and will focus on issues specific to the Indigenous community.
